* Aspen Aerogels Inc reported quarterly adjusted earnings of 19 cents​​ per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of -19 cents. The mean expectation of eleven analysts for the quarter was for a loss of 8 cents per share. Wall Street expected results to range from -20 cents to 15 cents per share.

* Revenue rose 93.1% to $117.34 million from a year ago; analysts expected $109.36 million.

* Aspen Aerogels Inc's reported EPS for the quarter was a loss of 17 cents​.

* The company reported a quarterly loss of $12.97 million.

* Aspen Aerogels Inc shares had fallen by 33.2% this quarter and gained 17.3% so far this year.

FORECAST CHANGES

* The mean earnings estimate of analysts had fallen by about 411% in the last three months.​

* In the last 30 days, seven analysts negatively revised earnings estimates

RECOMMENDATIONS

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 11 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

* The average consensus recommendation for the specialty chemicals peer group is also "buy"

Wall Street's median 12-month price target for Aspen Aerogels Inc is 33.00 This summary was machine generated from LSEG data November 7 at 04:50 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,

MISSED

Sep. 30 2024 -0.08 0.19 Beat

Jun. 30 2024 0.05 0.21 Beat

Mar. 31 2024 -0.11 -0.02 Beat

Dec. 31 2023 -0.12 -0.01 Beat